Diabetes Clinical Trials in Minneapolis

Showing 341-360 of 472 trials

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

NCT01072565

The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.

Type 2 Diabetes

HealthPartners Institute91 participantsStarted Feb 2010

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients

NCT00569959

This study will examine whether fasting and non-fasting lipid measures can provide similar clinical information in order to guide lipid management by primary physicians. It will compare fasting vs. non-fasting lipid measurements in patients with and without diabetes.

Diabetes MellitusNormal Glucose MetabolismHyperlipidemia

HealthPartners Institute50 participantsStarted Nov 2006

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

NCT01390610

The purpose of this study is to use data from the Continuous Glucose Monitoring (CGM) device and your Self-Monitored Blood Glucose (SMBG) levels to determine the best times to test blood glucose levels using SMBG.

Diabetes Mellitus, Type 2Diabetic Blood Glucose Monitoring

HealthPartners Institute27 participantsStarted Jun 2011

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

NCT02112071

The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).

Focus Type 2 Diabetes Related Chronic Kidney Disease

University of Minnesota122 participantsStarted Oct 2009

Minneapolis, Minnesota, United States

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients

Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

Diabetes Trials in Other Cities

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Effect on Weight Loss of Exenatide Versus Placebo

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Multiple Ascending Dose Study in Subjects With Type 2 Diabetes

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Other Conditions in Minneapolis